GREGORY T. LUCIER - 08 Dec 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role: Director
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier
Issuer symbol: XRAY
Transactions as of: 08 Dec 2025
Transactions value $: -$915,708
Form type: 4
Filing time: 10 Dec 2025, 16:26:27 UTC
Previous filing: 09 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LUCIER GREGORY T	Director	C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier	10 Dec 2025	0001251299

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XRAY	Common Stock	Sale	-$916K	-82.2K	-100%	$11.14	0	08 Dec 2025	Direct	F1, F2
holding	XRAY	Common Stock						24.6K	08 Dec 2025	By Family Partnership	F1
holding	XRAY	Common Stock						21K	08 Dec 2025	By Gregory Lucier IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Share numbers were adjusted to include dividend accruals paid on the shares.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.04 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Share numbers were adjusted to include dividend accruals paid on the shares.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.04 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.